Rodman & Renshaw Downgrades Edwards Lifesciences (EW) to Market Underperform
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $91.60 -1.04%
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
31 Buy, 14 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Rodman & Renshaw downgraded Edwards Lifesciences (NYSE: EW) from Market Perform to Market Underperform with a price target of $66.00.
For more ratings news on Edwards Lifesciences click here and for the rating history of Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $77.91 yesterday.
For more ratings news on Edwards Lifesciences click here and for the rating history of Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $77.91 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Barclays Downgrades Murphy Oil Corp. (MUR) to Underweight
- Goldman Sachs Downgrades Douglas AG (DOU:GR) to Sell
Create E-mail Alert Related Categories
DowngradesRelated Entities
Rodman & RenshawSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
